Assessing medication burden and polypharmacy: finding the perfect measure

References

• Hilmer SN , Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther. 2009;85:86–88.
   PubMed Web of Science ®Google Scholar
• Gnjidic D , Hilmer SN , Blyth F , et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiology. 2012;65:989–995.
   PubMed Web of Science ®Google Scholar
• Gnjidic D , Hilmer SN , Blyth F , et al. High risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharmacol Ther. 2012;91:521–528.
   PubMed Web of Science ®Google Scholar
• Kantor ED , Rehm CD , Haas JS , et al. Trends in prescription drug use among adults in the United States from 1999-2012. JAMA. 2015;314:1818–1831.
   PubMed Web of Science ®Google Scholar
• Hubbard RE , Peel NM , Scott IA , et al. Polypharmacy among inpatients aged 70 years or older in Australia. Med J Aust. 2015;202:373–377.
   PubMed Web of Science ®Google Scholar
• Tjia J , Briesacher BA , Peterson D , et al. Use of medications of questionable benefit in advanced dementia. JAMA Intern Med. 2014;174:1763–1771.
   PubMed Web of Science ®Google Scholar
• Fried TR , O’Leary J , Towle V , et al. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014;62:2261–2272.
   PubMed Web of Science ®Google Scholar
• Payne RA , Abel GA , Avery AJ , et al. Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care. Br J Clin Pharmacol. 2014;77:1073–1082.
   PubMed Web of Science ®Google Scholar
• Lorgunpai SJ , Grammas M , Lee DS , et al. Potential therapeutic competition in community-living older adults in the US: use of medications that may adversely affect a coexisting condition. PLoS One. 2014;9:e89447.
   PubMed Web of Science ®Google Scholar
• Farmer C , Fenu E , O’Flynn N , et al. Clinical assessment and management of multimorbidity: summary of NICE guidance. BMJ. 2016;354:i4843.
   PubMed Web of Science ®Google Scholar
• Jaspers Focks J , Brouwer MA , Wojdyla DM , et al. Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial. BMJ. 2016;353:i2868.
   PubMed Web of Science ®Google Scholar
• Gnjidic D , Bennett A , Le Couteur DG , et al. Ischemic heart disease, prescription of optimal medical therapy and geriatric syndromes in community-dwelling older men: a population-based study. Int J Cardiol. 2015;192:49–55.
   PubMed Web of Science ®Google Scholar
• Peeters G , Tett SE , Hollingworth SA , et al. Associations of guideline recommended medications for acute coronary syndromes with fall-related hospitalizations and cardiovascular events in older women with ischemic heart disease. J Gerontol A Biol Sci Med Sci. 2017; 72:259–265.
   PubMed Web of Science ®Google Scholar
• Tinetti ME , McAvay G , Trentalange M , et al. Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study. BMJ. 2015;351:h4984.
   PubMedGoogle Scholar
• Allore HG , Zhan Y , Cohen AB , et al. Methodology to estimate the longitudinal average attributable fraction of guideline-recommended medications for death in older adults with multiple chronic conditions. J Gerontol A Biol Sci Med Sci. 2016;71:1113–1116.
   PubMed Web of Science ®Google Scholar
• Jamsen KM , Bell JS , Hilmer SN , et al. Effects of changes in number of medications and drug burden index exposure on transitions between frailty states and death: the concord health and ageing in men project cohort study. J Am Geriatr Soc. 2016;64:89–95.
   PubMed Web of Science ®Google Scholar
• Reeve E , Gnjidic D , Long J , et al. A systematic review of the emerging defi nition of ‘deprescribing’ with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80:1254–1268.
   PubMed Web of Science ®Google Scholar
• Gnjidic D , Le Couteur DG , Hilmer SN. Discontinuing drug treatments. BMJ. 2014;349:g7013.
   PubMed Web of Science ®Google Scholar
• Patterson SM , Cadogan CA , Kerse N , et al. Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev. 2014;10:CD008165.
   PubMed Web of Science ®Google Scholar
• Scott IA , Hilmer SN , Reeve E , et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Internal Med. 2015;175:827–834.
   PubMed Web of Science ®Google Scholar
• Jansen J , Naganathan V , Carter SM , et al. Too much medicine in older people? Deprescribing through shared decision making. BMJ. 2016;353:i2893.
   PubMedGoogle Scholar